Lynda Charters

Pearls for implanting the port delivery device with ranibizumab.

The team conducted a cross-sectional study from December 2016 to March 2024 in patients with acute infectious conjunctivitis

During a recent Ophthalmology Times Case-Based Roundtable discussion, Albert S. Khouri, MD, shared his pearls in proactive glaucoma management.

The growing body of evidence that suggests that maintaining adequate levels of vitamin D may be beneficial for preventing and managing RVO.

Physicians share comprehensive approaches during roundtable discussion.

The authors explained that estimating the number of such visits in the US may help guide research and clinical efforts to optimize outcomes.

The study helped identify predisposing factors for severe SANS in astronauts.

iStent implantations increased sharply, whereas trabeculectomies saw a decline.

Lens feathering resulting from intraocular gas can interfere with the visualization needed to perform posterior segment surgery

CVD may interfere with an eye care provider’s ability to differentiate between choroidal melanoma and choroidal nevus

Researchers note work may lead to targets for conventional outflow pathway therapies.

Therapeutics can prevent vision loss and neurodegeneration in patients.

Researchers train deep learning model on OCT scans to ID patients eligible for GA trials.

The purpose of the study was to determine if experience affects the surgeons’ dexterity response to pharmacologic and behavioral interventions.

The key factor may be the control of inflammation.

Investigators conducted a case-control study to investigate the corneal topography parameters and biomechanics in patients with alopecia areata

A novel formulation may prevent blood vessel growth and vascular leakage in the retina.

Prescriptions with semaglutide (Wegovy, Ozempic, Novo Nordisk) are FDA approved to treat obesity and type 2 diabetes, respectively.

NVK002 atropine 0.01% (Vyluma Inc.) “meaningfully slowed” myopia progression in myopic pediatric patients over a 36-month period.

Technology offers increased usability, safety, and accuracy in MIGS procedures.

Comanagement is a key component for treatment of disease.

The SimVis Gekko eye dominance strength test may change the standard of care.

From amniotic membrane grafting to neurotization.

Repeated 0.1-ml intravireal injections of lampalizumab, antigen-binding fragment of a humanized monoclonal antibody that inhibits complement factor D, seem to be associated with a low risk of elevated IOP

Plasma emission for blepharitis, meibomian gland dysfunction, and dry eye disease.